null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

Pembrolizumab Biosimilar (Anti-PD-1) Antibody (HDBS0006)

SKU HDBS0006
Antibody Type Biosimilar Reference Antibody
Modifications PE-Conjugated
Applications IHC
Applications FC
Applications Drug Development
Applications Inflammatory Response Assays
Applications Pharmacokinetics
Disease Area Cancer Immunotherapy
Disease Area Autoimmune Diseases
Protein PD-1
Reactivity Human
Host Species Chimeric Humanized
Isotype IgG4
€431
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Pembrolizumab (Anti-PD-1) Biosimilar Antibody (HDBS0006)

The Anti-PD-1 Pembrolizumab Biosimilar MAb (HDBS0006) is a monoclonal antibody designed for research involving PD-1, a cell surface receptor that plays a key role in regulating immune responses. The antibody is highly specific and reactive with human samples, making it ideal for use in various research applications including Western blotting and immunohistochemistry.PD-1, also known as programmed cell death protein 1, is an immune checkpoint protein that inhibits T cell activation and plays a critical role in maintaining immune tolerance.

Blockade of PD-1 has shown promise in the treatment of various cancers by restoring T cell function and activating anti-tumor immune responses. The Anti-PD-1 Pembrolizumab Biosimilar MAb (HDBS0006) is a valuable tool for studying the role of PD-1 in cancer immunotherapy and for developing novel therapies that target this immune checkpoint pathway. Its high specificity and sensitivity make it a reliable reagent for researchers working in the fields of immunology, oncology, and drug development.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose